Aktien Sensor

Macquarie’s acquisition of Luz Saude is a high-stakes gamble that has sparked intense scrutiny, with investors questioning whether the company’s valuation and decision to enter the Portuguese healthcare market is justified.

Macquarie Group’s reputation is under threat as investor discontent and a declining stock price put pressure on the company’s business model.

Macquarie Group’s Chief Financial Officer, Alex Harvey, is stepping down after nearly three decades with the company, amidst regulatory scrutiny and declining net profit.

Macquarie Group’s profits plummeted in the first quarter of 2026, despite some divisions showing improved performance, leading to a leadership shake-up and questions about the company’s future direction.

Macquarie Group is facing a regulatory storm and investor scrutiny after a decline in net profit contribution and a sudden change in leadership.

Macquarie, a major Australian financial services company, is facing intense regulatory scrutiny after a lawsuit was filed by the ASIC alleging misreporting of short sales.

Macquarie, an Australian financial services company, is facing a lawsuit from the Australian Securities and Investments Commission over alleged failures to properly report short sales.

Australian regulators have launched a scathing attack on Macquarie, alleging the financial giant has been misreporting short sales and threatening its reputation and the financial markets.

Macquarie, Australia’s largest financial services company, is facing regulatory scrutiny and potential financial consequences after being accused of misreporting short sales.

Macquarie, an Australian financial services giant, is facing a lawsuit from ASIC over alleged discrepancies in short sale reporting, but its stock price remains relatively stable.